chr2-190519164-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001142645.2(NEMP2):āc.233G>Cā(p.Gly78Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000414 in 1,546,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001142645.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NEMP2 | NM_001142645.2 | c.233G>C | p.Gly78Ala | missense_variant | 3/9 | ENST00000409150.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NEMP2 | ENST00000409150.8 | c.233G>C | p.Gly78Ala | missense_variant | 3/9 | 2 | NM_001142645.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000135 AC: 21AN: 155510Hom.: 0 AF XY: 0.0000971 AC XY: 8AN XY: 82360
GnomAD4 exome AF: 0.0000165 AC: 23AN: 1394720Hom.: 0 Cov.: 31 AF XY: 0.0000102 AC XY: 7AN XY: 687882
GnomAD4 genome AF: 0.000269 AC: 41AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 27AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2023 | The c.233G>C (p.G78A) alteration is located in exon 3 (coding exon 3) of the NEMP2 gene. This alteration results from a G to C substitution at nucleotide position 233, causing the glycine (G) at amino acid position 78 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at